These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25473904)

  • 1. Principled compassion.
    Nat Med; 2014 Dec; 20(12):1355. PubMed ID: 25473904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
    Servick K
    Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
    [No Abstract]   [Full Text] [Related]  

  • 3. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
    Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
    Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Congress Get 'Right to Try' Right?
    Kirkner RM
    Manag Care; 2018 May; 27(5):10-11. PubMed ID: 29763399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right-to-try laws: hope, hype, and unintended consequences.
    Bateman-House A; Kimberly L; Redman B; Dubler N; Caplan A
    Ann Intern Med; 2015 Nov; 163(10):796-7. PubMed ID: 26413841
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations to Facilitate Expanded Access to Investigational Therapies for Seriously Ill Patients.
    Jerome RN; Edwards TL; Boswell HC; Bernard GR; Harris PA; Pulley JM
    Acad Med; 2016 Mar; 91(3):305-9. PubMed ID: 26445080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
    Hoerger M
    Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting Patient Interests in Implementing the Federal Right to Try Act.
    Lynch HF; Zettler PJ; Sarpatwari A
    JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
    [No Abstract]   [Full Text] [Related]  

  • 9. The strange allure of state "right-to-try" laws.
    Zettler PJ; Greely HT
    JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
    [No Abstract]   [Full Text] [Related]  

  • 10. Minnesota's Right to Try law.
    Hermer LD
    Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Right to Try" laws.
    Begg CB; Kim K; Neaton JD
    Clin Trials; 2014 Oct; 11(5):519-20. PubMed ID: 25190026
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanded access rules pose quandary for drug developers.
    Mack GS
    Nat Biotechnol; 2009 Oct; 27(10):871-2. PubMed ID: 19816423
    [No Abstract]   [Full Text] [Related]  

  • 14. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
    Tsakopoulos A; Han J; Nodler H; Russo V
    Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
    [No Abstract]   [Full Text] [Related]  

  • 15. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
    Bateman-House A; Robertson CT
    JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
    Finkelstein PE
    AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
    [No Abstract]   [Full Text] [Related]  

  • 17. One Last Shot.
    Berlin J
    Tex Med; 2016 Jul; 112(7):33-8. PubMed ID: 27441422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right-to-Try Investigational Therapies for Incurable Disorders.
    Simmons Z
    Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1451-1457. PubMed ID: 28968371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The terminally ill, access to investigational drugs, and FDA rules.
    Blake V
    Virtual Mentor; 2013 Aug; 15(8):687-91. PubMed ID: 23937785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.